Dynamic dissolution: A step closer to predictive dissolution testing?

Molecular Pharmaceutics

Volumn 7, Issue 5, 2010, Pages 1374-1387

  McAllister, Mark ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

biorelevant dissolution; dissolution testing; dynamic dissolution; Oral drug delivery

Indexed keywords

DRUG;

DRUG ABSORPTION; DRUG SOLUBILITY; DYNAMICS; FORCE; GASTROINTESTINAL TRACT; PERFORMANCE; PHYSICAL STRESS; PREDICTION; PRIORITY JOURNAL; REVIEW; SIMULATION;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; HUMANS; INTESTINAL ABSORPTION; MODELS, BIOLOGICAL; SOLUBILITY;

EID: 77957742677     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp1001203     Document Type: Review

References (123)

1. Noyes, A. A.; Whitney, W. R. The rate of solution of solid substances in their own solutions J. Am. Chem. Soc. 1897, 19, 930-934
2. Edwards, L. J. The dissolution and diffusion of aspirin in aqueous media Trans. Faraday Soc. 1951, 47, 1191-1210
3. Dokoumetzidis, A.; Macheras, P. A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System Int. J. Pharm. 2006, 321 (1-2) 1-11
4. Fahr, A.; Liu, X. Drug delivery strategies for poorly water-soluble drugs Expert Opin. Drug Delivery 2007, 4 (4) 403-416
5. Merisko-Liversidge, E. M.; Liversidge, G. G. Drug nanoparticles: formulating poorly water-soluble compounds Toxicol. Pathol. 2008, 36 (1) 43-48
6. Brouwers, J.; Brewster, M. E.; Augustijns, P. Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability J. Pharm. Sci. 2009, 98 (8) 2549-2572
7. Serajuddin, A. T. M.; Li, P.; Haefele, T. F. Development of lipid-based drug delivery systems for poorly water-soluble drugs as viable oral dosage forms-present status and future prospects Am. Pharm. Rev. 2008, 11 (3) 34-42
8. Cole, E. T.; Cade, D.; Benameur, H. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration Adv. Drug Delivery Rev. 2008, 60 (6) 747-756
9. Stella, V. J.; He, Q. Cyclodextrins Toxicol. Pathol. 2008, 36 (1) 30-42
10. Andrews, G. P.; Jones, D. S.; Abu Diak, O.; Margetson, D. N.; McAllister, M. S. Hot-melt extrusion: an emerging drug delivery technology Pharm. Tech. Eur. 2009, 21 (1) 18-23
11. Vasconcelos, T.; Sarmento, B.; Costa, P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs Drug Discovery Today 2007, 12 (23-24) 1068-1075
12. Gray, V.; Kelly, G.; Xia, M.; Butler, C.; Thomas, S.; Mayock, S. The Science of USP 1 and 2 Dissolution: Present Challenges and Future Relevance Pharm. Res. 2009, 26 (6) 1289-1302
13. Charkoftaki, G.; Dokoumetzidis, A.; Valsami, G.; Macheras, P. Biopharmaceutical classification based on solubility and dissolution: a reappraisal of criteria for hypothesis models in the light of the experimental observations Basic Clin. Pharmacol. Toxicol. 2010, 106, 3168-172
14. D'Arcy, D. M.; Corrigan, O. I.; Healy, A. M. Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: Impact on dissolution rate and variability J. Pharm. Pharmacol 2005, 57 (10) 1243-1250
15. D'Arcy, D. M.; Corrigan, O. I.; Healy, A. M. Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics-Dissolution rate implications Eur. J. Pharm. Sci. 2006, 27 (2-3) 259-267
16. Fadda, H. M.; McConnell, E. L.; Short, M. D.; Basit, A. W. Meal-Induced Acceleration of Tablet Transit Through the Human Small Intestine Pharm. Res. 2009, 26 (2) 356-360
17. McConnell, E. L.; Fadda, H. M.; Basit, A. W. Gut instincts: Explorations in intestinal physiology and drug delivery Int. J. Pharm. 2008, 364 (2) 213-226
18. Weitschies, W.; Wedemeyer, R.-S.; Kosch, O.; Fach, K.; Nagel, S.; Soederlind, E.; Trahms, L.; Abrahamsson, B.; Moennikes, H. Impact of the intragastric location of extended release tablets on food interactions J. Controlled Release 2005, 108 (2-3) 375-385
19. Lennernas, H. Modeling Gastrointestinal drug absorption requires more In vivo Biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans Curr. Drug Metab. 2007, 8, 645-657
20. Abrahamsson, B.; Albery, T.; Eriksson, A.; Gustafsson, I.; Sjoberg, M. Food effects on tablet disintegration Eur. J. Pharm. Sci. 2004, 22 (2-3) 165-172
21. Bonlokke, L.; Hovgaard, L.; Kristensen, H. G.; Knutson, L.; Lennernas, H. Direct estimation of the in vivo dissolution of spironolactone, in two particle size ranges, using the single-pass perfusion technique (Loc-I-Gut) in humans Eur. J. Pharm. Sci. 2001, 12 (3) 239-250
22. Dressman, J. B.; Fleisher, D. Mixing-tank model for predicting dissolution rate control of oral absorption J. Pharm. Sci. 1986, 75 (2) 109-116
23. Dressman, J. B.; Vertzoni, M.; Goumas, K.; Reppas, C. Estimating drug solubility in the gastrointestinal tract Adv. Drug Delivery Rev. 2007, 59 (7) 591-602
24. Kostewicz, E. S.; Brauns, U.; Becker, R.; Dressman, J. B. Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media Pharm. Res. 2002, 19 (3) 345-349
25. Persson, E. M.; Gustafsson, A.-S.; Carlsson, A. S.; Nilsson, R. G.; Knutson, L.; Forsell, P.; Hanisch, G.; Lennernaes, H.; Abrahamsson, B. The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids Pharm. Res. 2005, 22 (12) 2141-2151
26. Porter, C. J. H.; Kaukonen, A. M.; Taillardat-Bertschinger, A.; Boyd, B. J.; O'Connor, J. M.; Edwards, G. A.; Charman, W. N. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine J. Pharm. Sci. 2004, 93) 5
27. Bonlokke, L.; Christensen, F. N.; Knutson, L.; Kristensen, H. G.; Lennernas, H. A new approach for direct in vivo dissolution studies of poorly soluble drugs Pharm. Res. 1997, 14 (10) 1490-1492 (Pubitemid 27481085)
28. Bonlokke, L.; Hovgaard, L.; Kristensen, H. G.; Knutson, L.; Lindahl, A.; Lennernas, H. A comparison between direct determination of in vivo dissolution and the deconvolution technique in humans Eur. J. Pharm. Sci. 1999, 8 (1) 19-27
29. Kalantzi, L.; Persson, E.; Polentarutti, B.; Abrahamsson, B.; Goumas, K.; Dressman, J. B.; Reppas, C. Canine Intestinal Contents vs. Simulated Media for the Assessment of Solubility of Two Weak Bases in the Human Small Intestinal Contents Pharm. Res. 2006, 23 (6) 1373-1381
30. Nyberg, L.; Månsson, W.; Abrahamsson, B.; Seidegård, J.; Borgå, O. A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: Experiences from thirteen phase I studies Eur. J. Pharm. Sci. 2007, 30 (5) 432-440
31. Persson, E. M.; Nilsson, R. G.; Hansson, G. I.; Loefgren, L. J.; Libaeck, F.; Knutson, L.; Abrahamsson, B.; Lennernaes, H. A Clinical Single-Pass Perfusion Investigation of the Dynamic in vivo Secretory Response to a Dietary Meal in Human Proximal Small Intestine Pharm. Res. 2006, 23 (4) 742-751
32. Galia, E.; Nicolaides, E.; Horter, D.; Lobenberg, R.; Reppas, C.; Dressman, J. B. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs Pharm. Res. 1998, 15 (5) 698-705
33. Grove, M.; Pedersen, G. P.; Nielsen, J. L.; Muellertz, A. Bioavailability of seocalcitol I: Relating solubility in biorelevant media with oral bioavailability in rats-effect of medium and long chain triglycerides J. Pharm. Sci. 2005, 94 (8) 1830-1838
34. Jantratid, E.; Janssen, N.; Reppas, C.; Dressman, J. B. Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update Pharm. Res. 2008, 25 (7) 1663-1676
35. Klein, S.; Butler, J.; Hempenstall, J. M.; Reppas, C.; Dressman, J. B. Media to simulate the postprandial stomach I. Matching the physicochemical characteristics of standard breakfasts J. Pharm. Pharmacol. 2004, 56 (5) 605-610
36. Lue, B.-M.; Nielsen, F. S.; Magnussen, T.; Schou, H. M.; Kristensen, K.; Jacobsen, L. O.; Muellertz, A. Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compound Eur. J. Pharm. Biopharm. 2008, 69 (2) 648-657
37. Vertzoni, M.; Dressman, J.; Butler, J.; Hempenstall, J.; Reppas, C. Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds Eur. J. Pharm. Biopharm. 2005, 60 (3) 413-417
38. Vertzoni, M.; Fotaki, N.; Kostewicz, E.; Stippler, E.; Leuner, C.; Nicolaides, E.; Dressman, J.; Reppas, C. Dissolution media simulating the intralumenal composition of the small intestine: Physiological issues and practical aspects J. Pharm. Pharmacol. 2004, 56 (4) 453-462
39. Vertzoni, M.; Pastelli, E.; Psachoulias, D.; Kalantzi, L.; Reppas, C. Estimation of Intragastric Solubility of Drugs Pharm. Res. 2007, 24 (5) 909-917
40. Schiller, C.; Frohlich, C.-P.; Giessmann, T.; Siegmund, W.; Monnikes, H.; Hosten, N.; Weitschies, W. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging Aliment. Pharmacol. Ther. 2005, 22 (10) 971-979
41. Dokoumetzidis, A.; Kalantzi, L.; Fotaki, N. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models Expert Opin. Drug Metab. Toxicol. 2007, 3 (4) 491-505
42. Jones, H. M.; Parrott, N.; Ohlenbusch, G.; Lave, T. Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling Clin. Pharmacokinet. 2006, 45 (12) 1213-1226
43. Kuentz, M.; Nick, S.; Parrott, N.; Roethlisberger, D. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study Eur. J. Pharm. Sci. 2006, 27 (1) 91-99
44. Naylor, T. A.; Connolly, P. C.; Martini, L. G.; Elder, D. P.; Minekus, M.; Havenaar, R.; Zeijdner, E. Use of a gastro-intestinal model and GastroplusTM for the prediction of in vivo performance Appl. Ther. Res. 2006, 6 (1) 15-19
45. Okumu, A.; DiMaso, M.; Lobenberg, R. Dynamic Dissolution Testing To Establish In vitro/In vivo Correlations for Montelukast Sodium, a Poorly Soluble Drug Pharm. Res. 2008, 25 (12) 2778-2785
46. Abrahamsson, B.; Pal, A.; Sjoberg, M.; Carlsson, M.; Laurell, E.; Brasseur, J. G. A novel in vitro and numerical analysis of shear-induced drug release from extended-release tablets in the fed stomach Pharm. Res. 2005, 22 (8) 1215-1226
47. Diebold, S. M. Physiological parameters relevant to dissolution testing: hydrodynamic considerations. In Pharmaceutical Dissolution; Dressman, J. B.; Kramer, J., Eds.; Taylor & Francis: London, U.K., 2005; pp 127 - 191.
48. Kukara, J.; Baxter, J. L.; Muzzio, F. J. Shear distribution and variability in the USP apparatus 2 under turbulent conditions Int. J. Pharm. 2004, 279, 9-17
49. Diakidou, A.; Vertzoni, M.; Abrahamsson, B.; Dressman, J. B.; Reppas, C. Simulation of gastric lipolysis and prediction of felodipine release from a matrix tablet in the fed stomach Eur. J. Pharm. Sci. 2009, 37, 133-140
50. Fotaki, N.; Aivaliotis, A.; Butler, J.; Dressman, J. B.; Fischbach, M.; Hempenstall, J.; Klein, S.; Reppas, C. A comparative study of different release apparatus in generating in vitro-in vivo correlations for extended release formulations Eur. J. Pharm. Biopharm. 2009, 73, 115-120
51. Klein, S.; Rudolph, M.; Skalsy, B.; Petereit, H.-U.; Dressman, J. B. use of the BioDis to generate a physiologically relevant IVIVC J. Controlled Release 2008, 130, 216-219
52. Jantratid, E.; Janssen, N.; Chokshi, H.; Tang, K.; Dressman, J. B. Designing biorelevant dissolution tests for lipid formulations: Case example-Lipid suspension of RZ-50 Eur. J. Pharm. Biopharm. 2008, 69, 776-785
53. United States Pharmacopeia and National Formulary USP 29-NF 24; The United States Pharmacoeial Convention, Inc.: Rockville, MD, 2007.
54. Miller, D. A.; Gamba, M.; Sauer, D.; Purvis, T. P.; Clemens, N. T.; Williams, R. O., III. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence Int. J. Pharm. 2007, 330 (1-2) 61-72
55. Fotaki, N.; Vertzoni, M. Biorelevant dissolution methods and their applications in in vitro-in vivo correlations for oral formulations Open Drug Delivery J. 2010, 4, 2-13
56. Sunesen, V. H.; Pedersen, B. L.; Kristensen, H. G.; Mullertz, A. In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media Eur. J. Pharm. Sci. 2005, 24, 305-313
57. Perng, C.-Y.; Kearney, A. S.; Palepu, N. R.; Smith, B. R.; Azzarano, L. M. Assessment of oral bioavailability enhancing approaches for SB-247083 using flow-through cell dissolution testing as one of the screens Int. J. Pharm. 2003, 250 (1) 147-156
58. Gould, P. L. Salt selection for basic drugs Int. J. Pharm. 1986, 33, 201-217
59. Carino, S. R.; Sperry, D. C.; Hawley, M. Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model J. Pharm. Sci. 2006, 95 (1) 116-125
60. Castela-Papin, N.; Cai, S.; Vatier, J.; Keller, F.; S, C. H.; Farinotti, R. Drug interactions with diosmectite: a study using the artificial stomach-duodenum model Int. J. Pharm. 1999, 182, 111-119
61. Vatier, J.; Celice-Pingaud, C.; Farinotti, R. A computerized artificial stomach model to assess sodium alginate-induced pH gradient Int. J. Pharm. 1998, 163 (1-2) 225-229
62. Hawley, M.; Douglas, S.; Morozowich, W. Poster 2448. In AAPS Annual Meeting. 1998.
63. San Francisco, CA: PharmSci.
64. Stahl, P. H.; Nakano, M. Pharmaceutical aspects of the drug salt form. In Handbook of Pharmaceutical Salts; Stahl, P. H., Ed.; 2008; pp 83 - 116.
65. Kostewicz, E.; Wunderlich, M.; Brauns, U.; Becker, R.; Bock, T.; Dressman, J. B. Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine J. Pharm. Pharmacol. 2004, 56, 43-51
66. Cassilly, D.; Kantor, S.; Knight, L. C.; Maurer, A. H.; Fisher, R. S.; Semler, J.; Parkman, H. P. Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy Neurogastroenterol. Motil. 2008, 20, 311-319
67. Goodman, K.; Hodges, L. A.; Band, J.; Stevens, H.; Werner, W. Assessing gastrointestinal motility and disintegration profiles of magnetic tabelts by a novel magnetic imaging device and gamma scintigraphy Eur. J. Pharm. Biopharm. 2010, 74 (1) 82-92
68. Weitschies, W.; Blume, H.; Monnikes, H. Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract Eur. J. Pharm. Biopharm. 2010, 74, 93-101
69. Garbacz, G.; Wedemeyer, R.-S.; Nagel, S.; Giessmann, T.; Moennikes, H.; Wilson, C. G.; Siegmund, W.; Weitschies, W. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses Eur. J. Pharm. Biopharm. 2008, 70 (2) 421-428
70. Weitschies, W.; Cardini, D.; Karaus, M.; Trahms, L.; Semmler, W. Magnetic marker monitoring of esophageal, gastric, and duodenal transit of non-disintegrating capsules Pharmazie 1999, 54 (6) 426-430
71. Weitschies, W.; Kosch, O.; Moennikes, H.; Trahms, L. Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms Adv. Drug Delivery Rev. 2005, 57 (8) 1210-1222
72. Burke, M.; Maheshwari, C. R.; Zimmerman, B. O. Pharmaceutical analysis apparatus and method; USA Pat.
73. Takano, R.; Furumoto, K.; Shiraki, K.; Takata, N.; Hayashi, Y.; Aso, Y.; Yamashita, S. Rate-Limiting Steps of Oral Absorption for Poorly Water-Soluble Drugs in Dogs; Prediction from a Miniscale Dissolution Test and a Physiologically-Based Computer Simulation Pharm. Res. 2008, 25 (10) 2334-2344
74. Grassi, M.; Coceani, N.; Magarotto, L. Modeling partitioning of sparingly soluble drugs in a two-phase liquid system Int. J. Pharm. 2002, 239 (1-2) 157-169
75. Shi, Y.; Gao, P. In vitro test method for poorly soluble drugs. In AAPS Annual Symposium 2009,: Los Angeles.
76. Vangani, S.; Li, X.; Zhou, P.; Del-Barrio, M.-A.; Chiu, R.; Cauchon, N.; Gao, P.; Medina, C.; Jasti, B. Dissolution of poorly water-soluble drugs inbiphasic media using USP 4 and fiber optic system Clin. Res. Regul. Affairs 2009, 26 (1-2) 8-19
77. Gu, C.-H.; Rao, D.; Gandhi, R. B.; Hilden, J.; Raghavan, K. Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility J. Pharm. Sci. 2005, 94 (1) 199-208
78. Fallingborg, J. Intraluminal pH of the human gastrointestinal tract Dan. Med. Bull. 1999, 46, 183-196
79. Kararli, T. Composition of the gastrointestinal anatomy, physiology and biochemistry of humans and commonly used laboratory animals Biopharm. Drug Dispos. 1995, 16, 351-380
80. Lyn Hughes, P. Session 6: BCS extensions and method development challenges-new GI dissolution testing technology. [cited; Available from: http://www.aapspharmaceutica.com/meetings/distance/webcasts/.
81. Thoma, K.; Ziegler, I. Development of an automated flow-through dissolution system for poorly soluble drugs with poor chemical stability in dissolution media Pharmazie 1998, 53, 784-790
82. Sunesen, V. H.; Pedersen, B. L.; Kristensen, H. G.; Mulletz, A. In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelavent dissolution media Eur. J. Pharm. Sci. 2005, 24, 305-313
83. Okumu, A.; DiMaso, M.; Loebenberg, R. Computer simulations using GastroPlus to justify a biowaiver for etoricoxib solid oral drug products Eur. J. Pharm. Biopharm. 2009, 72 (1) 91-98
84. Shono, Y.; Jantratid, E.; Janssen, N.; Kesisoglou, F.; Mao, Y.; Vertzoni, M. Prediction of food effects on the absoprtion of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling Eur. J. Pharm. Biopharm. 2009, 73, 107-114
85. Buch, P.; Langguth, P.; Kataoka, M.; Yamashita, S. IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution/permeation system J. Pharm. Sci. 2009, 98 (6) 2001-2009
86. Kataoka, M.; Masaoka, Y.; Sakuma, S.; Yamashita, S. Effect of food intake on the oral absorption of poorly water-soluble drugs: in vitro assessment of drug dissolution and permeation assay system J. Pharm. Sci. 2006, 95 (9) 2051-2061
87. Kataoka, M.; Masaoka, Y.; Yamazaki, Y.; Sakane, T.; Sezaki, H.; Yamashita, S. In vitro System to Evaluate Oral Absorption of Poorly Water-Soluble Drugs: Simultaneous Analysis on Dissolution and Permeation of Drugs Pharm. Res. 2003, 20 (10) 1674-1680
88. Yano, K.; Masaoka, Y.; Kataoka, M.; Sakuma, S.; Yamashita, S. Mechanisms of membrane transport of poorly soluble drugs: Role of micelles in oral absorption processes J. Pharm. Sci. 2010, 99 (3) 1336-1345
89. Ginski, M. J.; Polli, J. E. Prediction of dissolution-absorption relationships from a dissolution/Caco-2 system Int. J. Pharm. 1999, 177 (1) 117-125
90. Yamashita, S.; Furubayashi, T.; Kataoka, M.; Sakane, T.; Sezaki, H.; Tokuda, H. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells Eur. J. Pharm. Sci. 2000, 10, 195-204
91. Kobayashi, M.; Sada, N.; Sugawara, M.; Iseki, K.; Miyazaki, K. Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract Int. J. Pharm. 2001, 221, 87-94
92. Motz, S. A.; Schaefer, U. F.; Balbach, S.; Eichinger, T.; Lehr, C. M. Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell Eur. J. Pharm. Biopharm. 2007, 66, 286-295
93. Sugawara, M.; Kadomura, S.; He, X.; Takekuma, Y.; Kohri, N.; Miyazaki, K. The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulations Eur. J. Pharm. Sci. 2005, 26, 1-8
94. Gao, P.; Morozowich, W. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs Expert Opin. Drug Delivery 2006, 3, 97-110
95. Amidon, G. E.; Higuchi, W. I.; Ho, N. F. Theoretical and experimental studies of transport of micelle solubilized solutes J. Pharm. Sci. 1982, 71, 77-84
96. Fatouros, D.; Mullertz, A. In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability Expert Opin. Drug Metab. Toxicol. 2008, 4 (1) 65-76
97. Zangenberg, N. H.; Muellertz, A.; Kristensen, H. G.; Hovgaard, L. A dynamic in vitro lipolysis model: II: Evaluation of the model Eur. J. Pharm. Sci. 2001, 14 (3) 237-244
98. Zangenberg, N. H.; Müllertz, A.; Kristensen, H. G.; Hovgaard, L. A dynamic in vitro lipolysis model: I. Controlling the rate of lipolysis by continuous addition of calcium Eur. J. Pharm. Sci. 2001, 14 (2) 115-122
99. Fatouros, D.; Muellertz, A. Using in vitro dynamic lipolysis modelling as a tool for exploring IVIVC relationships for oral lipid-based formulations. In: Lipid-based formulations for Oral drug delivery. In Drugs and the Pharmaceutical Sciences; Hauss, D., Ed.; Taylor Francis: 2007; pp 257 - 273.
100. Porter, C. J. H.; Kaukonen, A. M.; Taillardat-Bertschinger, A.; Boyd, B. J.; O'Connor, J. M.; Edwards, G. A.; Charman, W. N. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: Studies with halofantrine J. Pharm. Sci. 2004, 93 (5) 1110-1121
101. Dahan, A.; Hoffman, A. The effect of different lipid nased formulations on the oral absoprtion of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats Eur. J. Pharm. Biopharm. 2007, 67 (1) 96-105
102. Marciani, L.; Gowland, P. A.; Fillery-Travis, A.; Manoj, P.; Wright, J.; Smith, A.; Young, P.; Moore, R.; Spiller, R. C. Assessment of antral grinding of a model solid meal with echo-planar imaging Am. J. Physiol. 2001, 280 (5, Part 1) G844-G849
103. Marciani, L.; Gowland, P. A.; Spiller, R. C.; Manoj, P.; Moore, R. J.; Young, P.; Al-Sahab, S.; Bush, D.; Wright, J.; Fillery-Travis, A. J. Gastric response to increased meal viscosity assessed by echo-pl anar magnetic resonance ima ging in humans J. Nutr. 2000, 130 (1) 122-127
104. Marciani, L.; Gowland, P. A.; Spiller, R. C.; Manoj, P.; Moore, R. J.; Young, P.; Fillery-Travis, A. J. Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI Am. J. Physiol. 2001, 280 (6, Part 1) G1227-G1233
105. Marciani, L.; Wickham, M.; Hills, B. P.; Wright, J.; Bush, D.; Faulks, R.; Fillery-Travis, A.; Spiller, R. C.; Gowland, P. A. Intragastric oil-in-water emulsion fat fraction measured using inversion recovery echo-planar magnetic resonance imaging J. Food Sci. 2004, 69 (6 E290-E296
106. Wickham, M.; Faulks, R.; Mills, C. In vitro digestion methods for assessing the effect of food structure on allergen breakdown Mol. Nutr. Food Res. 2009, 53 (8) 952-958
107. Mercuri, A.; Lo Curto, A.; Wickham, M. S. J.; Craig, D. Q. M.; A., B. S. Dynamic gastric model (DGM): a novel in vitro apparatus to assess the impact of gastric digestion on the droplet size of self-emulsifying drug-delivery systems J. Pharm. Pharmacol. 2008, 60 (Suppl. 1) A-2
108. Blanquet, S.; Zeijdner, E.; Beyssac, E.; Meunier, J.-P.; Denis, S.; Havenaar, R.; Alric, M. A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions Pharm. Res. 2004, 21 (4) 585-591
109. Minekus, M.; Marteau, P.; Havenaar, R.; Huis in 't Veld, J. H. J. A multi compartmental dynamic computer-controlled model simulating the stomach and small intestine ATLA, Altern. Lab. Anim. 1995, 23, 197-209
110. Verwei, M.; Freidig, A. P.; Havenaar, R.; Groten, J. P. Predicted serum folate concentrations based on in vitro studies and kinetic modeling are consistent with measured folate concentrations in humans J. Nutr. 2006, 136, 3074-3078
111. Krul, C. A. M.; Luiten-Schuite, A.; Baan, R.; Verhagen, H.; Mohn, G.; Feron, V.; Havenaar, R. Application of a dynamic in vitro gastrointestinal tract model to study the availability of food mutagens, using heterocyclic aromatic amines as model compounds Food Chem. Toxicol. 2000, 38, 783-792
112. Larsson, M.; Minekus, M.; Havenaar, R. Estimation of the bio-availability of iron and phosphorus in cereals using a dynamic in-vitro gastrointestinal model J. Sci. Food Agric. 1997, 73, 99-106
113. Verwei, M.; Arkbåge, K.; Havenaar, R.; VandenBerg, H.; Witthöft, C.; Schaafsma, G. Folic acid and 5-Methyl-tetrahydrofolate in fortified milk are bioaccessible as determined in a dynamic in vitro gastrointestinal model J. Nutr. 2003, 133, 2377-2383
114. Ameer, B.; Divoll, M.; Abernethy, D. R.; Greenblatt, D. J.; Shargel, L. Absolute and relative bioavailability of oral acetaminophen preparations J. Pharm. Sci. 1983, 72 (8) 955-958 (Pubitemid 13040661)
115. Divoll, M.; Greenblatt, D. J.; Ameer, B.; Abernethy, D. R. Effect of food on acetaminophen absorption in young and elderly subjects J. Clin. Pharmacol. 1982, 22 (11-12) 571-576
116. Rostami-Hodjegan, A.; Shiran, M. R.; Ayesh, R.; Grattan, T. J.; Burnett, I.; Darby-Dowman, A.; Tucker, G. T. A new rapidly absorbed paracetamol tablet containing sodium bicarbonate. I. A four-way crossover study to compare the concentration-time profile of paracetamol from the new paracetamol/sodium bicarbonate tablet and a conventional paracetamol tablet in fed and fasted volunteers Drug Dev. Ind. Pharm. 2002, 28 (5) 523-531
117. Rygnestad, T.; Zahlsen, K.; Samdal, F. A. Absorption of effervescent paracetamol tablets relative to ordinary paracetamol tablets in healthy volunteers Eur. J. Clin. Pharmacol. 2000, 56 (2) 141-143
118. Souliman, S.; Blanquet, S.; Beysac, E.; Cardot, J.-M. A level A in vitro/in vivo correlation in fasted and fed states using different methods: Applied to solid immediate release oral dosage from Eur. J. Pharm. Sci. 2006, 27 (1) 72-79
119. Tenjarla, S.; Romasanta, V.; Zeijdner, E.; Villa, R.; Moro, L. Release of 5-aminosalicylate from an MMX mesalamine tablet during transit through a simulated gastrointestinal tract system Adv. Ther. 2007, 24 (4) 826-840
120. Kamm, M. A.; Sandborn, W. J.; Gassull, M.; Schreiber, S.; Jackowski, L.; Butler, T.; Lyne, A.; Stephenson, D.; Palmen, M.; Joseph, R. E. Once-daily, high-concentration MMX mesalamine in active ulcerative colitis Gastroenterology 2007, 132 (1) 66-75
121. Lichtenstein, G. R.; Kamm, M. A.; Boddu, P.; Gubergrits, N.; Lyne, A.; Butler, T.; Lees, K.; Joseph, R. E.; Sandborn, W. J. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis Clin. Gastroenterol. Hepatol. 2007, 5 (1) 95-102
122. Souliman, S.; Beyssac, E.; Cardot, J.-M.; Denis, S.; Alric, M. Investigation of the biopharmaceutical behavior of theophylline hydrophilic matrix tablets using USP methods and an artificial digestive system Drug Dev. Ind. Pharm. 2007, 33 (4) 475-483
123. Deat, E.; Blanquet-Diot, S.; Jarrige, J.-F.; Denis, S.; Beyssac, E.; Alric, M. Combining the Dynamic TNO-Gastrointestinal Tract System with a Caco-2 Cell Culture Model: Application to the Assessment of Lycopene and.alpha.-Tocopherol Bioavailability from a Whole Food J. Agric. Food Chem. 2009, 57 (23) 11314-11320